EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A DNA Methylation Signature Predicts Survival and Platinum Response in HNSCC

Riya Chhabra iD, Alfred Kao, Omar Mokhashi, Wei Tse Li, Daniel John, Jessica Wang-Rodriguez, Weg M Ongkeko

Laryngoscope Investigative Otolaryngology · 2026-06 · 11 (3)

DOI: 10.1002/lio2.70461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngoscope Investigative Otolaryngology, online erschienen am 07.06.2026. Verfasst von Riya Chhabra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology- Head and Neck Surgery University of California San Diego California USA. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to develop and validate a DNA methylation–based risk score to identify patients at higher risk of poor survival and platinum non‐response.

Methods

Genome‐wide DNA methylation and clinical data, including treatment response and survival, were analyzed from platinum‐treated patients with head and neck squamous cell carcinoma in The Cancer Genome Atlas ( n = 153). A weighted DNA methylation risk score was constructed from response‐associated methylation features and evaluated for associations with overall survival and platinum treatment response. Prognostic performance was assessed using Kaplan–Meier analysis and multivariable Cox regression. Predictive performance for platinum response was evaluated by comparing models incorporating methylation features with models based on clinical variables alone. External validation was performed in an independent oral rinse–based methylation cohort (GSE52793, n = 82).

Results

The methylation risk score significantly stratified overall survival (HR = 3.03, 95% CI: 1.20–7.65; p = 0.019). Incorporation of the risk score improved prediction of platinum response compared with clinical variables alone in both logistic regression (AUC 0.58 vs. 0.80) and random forest models (AUC 0.66 vs. 0.90). Prognostic performance was preserved in an independent oral rinse–based validation cohort (HR = 1.043; p = 0.019).

Conclusion

A DNA methylation–based risk score stratifies survival and improves prediction of platinum response in head and neck squamous cell carcinoma beyond standard clinical factors. Validation in an oral rinse–based cohort highlights the potential clinical applicability of methylation biomarkers for non‐invasive treatment risk stratification and supports prospective evaluation. Level of Evidence 3.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationepigenetic biomarkershead and neck squamous cell carcinomaplatinum‐based chemotherapyprognosistreatment response prediction

Autor:innen und Institutionen

  • Department of Otolaryngology- Head and Neck Surgery University of California San Diego California USA.
  • Research Service VA San Diego Healthcare System San Diego California USA.
  • UCSF School of Medicine University of California San Francisco California USA.
  • Department of Pathology University of California San Diego California USA.
  • Pathology Service VA San Diego Healthcare System San Diego California USA.

ORCID-Profile: Riya Chhabra

Zitieren

APA

Chhabra, R., Kao, A., Mokhashi, O., Li, W. T., John, D., Wang-Rodriguez, J., & Ongkeko, W. M. (2026). A DNA Methylation Signature Predicts Survival and Platinum Response in HNSCC. Laryngoscope Investigative Otolaryngology, 11(3). https://doi.org/10.1002/lio2.70461

Vancouver

Chhabra R, Kao A, Mokhashi O, Li WT, John D, Wang-Rodriguez J, et al. A DNA Methylation Signature Predicts Survival and Platinum Response in HNSCC. Laryngoscope Investigative Otolaryngology. 2026;11(3). doi:10.1002/lio2.70461

BibTeX
@article{Chhabra2026,
  author = {Chhabra, Riya and Kao, Alfred and Mokhashi, Omar and Li, Wei Tse and John, Daniel and Wang-Rodriguez, Jessica and Ongkeko, Weg M},
  title = {A DNA Methylation Signature Predicts Survival and Platinum Response in HNSCC},
  journal = {Laryngoscope Investigative Otolaryngology},
  year = {2026},
  volume = {11},
  number = {3},
  doi = {10.1002/lio2.70461}
}
Kostenlos starten →